SHARE-BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Mar. 16, 2023	Jan. 28, 2024	Jan. 29, 2023	Mar. 15, 2023
Share-based Compensation [Abstract]
Maximum number of shares of common stock that may be issued (in shares)	5,000,000			4,000,000
Additional shares available for issuance (in shares)	1,000,000
Expense incurred		$ 2,573	$ 1,821
Income tax benefits of share-based compensation		99	155
Share-based compensation cost capitalized		0	0
Cost of Goods Sold [Member]
Share-based Compensation [Abstract]
Expense incurred		595	281
Selling, General and Administrative [Member]
Share-based Compensation [Abstract]
Expense incurred		1,749	1,378
Research and Development [Member]
Share-based Compensation [Abstract]
Expense incurred		229	162
Restricted Stock [Member]
Share-based Compensation [Abstract]
Expense incurred		$ 2,573	$ 1,764
Restricted Stock [Abstract]
Number of shares granted in period (in shares)		825,050	786,500
Weighted-average grant-date fair value of awards (in dollars per share)		$ 29.77	$ 16.77
Shares outstanding at balance sheet date (in shares)		1,634,315	1,374,422
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized		$ 31,426	$ 18,526
Weighted-average amortization period for cost not yet recognized (in years)		3 years 3 months 18 days	3 years 2 months 12 days
Restricted Stock [Member] | Minimum [Member]
Share-based Compensation [Abstract]
Award vesting period		1 year
Restricted Stock [Member] | Maximum [Member]
Share-based Compensation [Abstract]
Award vesting period		4 years
Stock Options [Member]
Share-based Compensation [Abstract]
Expense incurred		$ 0	$ 1
Stock options activity [Abstract]
Contractual term		10 years
Number of options granted in period (in shares)		0	0
Cash received from options exercised		$ 936	$ 563
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized		$ 0	0
Outstanding and exercisable option awards [Roll Forward]
Outstanding at end of period (in shares)		375,525
Exercisable at end of period (in shares)		375,525
Weighted-Average Exercise Price [Abstract]
Outstanding at end of period (in dollars per share)		$ 10.31
Exercisable at end of period (in dollars per share)		$ 10.31
Weighted-Average Remaining Contractual Life (in years) [Abstract]
Outstanding at end of period		2 years 7 months 2 days
Exercisable at end of period		2 years 7 months 2 days
Aggregate Intrinsic Value [Abstract]
Outstanding at end of period		$ 7,448
Exercisable at end of period		$ 7,448
Stock Options [Member] | Minimum [Member]
Share-based Compensation [Abstract]
Award vesting period		1 year
Stock Options [Member] | Maximum [Member]
Share-based Compensation [Abstract]
Award vesting period		4 years
Employee Stock Purchase Plan [Member]
Share-based Compensation [Abstract]
Expense incurred		$ 0	$ 56